Mannatech (NASDAQ:MTEX) Share Price Passes Below 200-Day Moving Average – Should You Sell?

Shares of Mannatech, Incorporated (NASDAQ:MTEX) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $8.86 and traded as low as $7.56. Mannatech shares last traded at $7.86, with a volume of 10,730 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Mannatech in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Mannatech Price Performance

The business has a 50-day moving average price of $8.98 and a two-hundred day moving average price of $8.86. The company has a quick ratio of 0.56, a current ratio of 1.13 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $14.93 million, a price-to-earnings ratio of -9.14 and a beta of 0.79.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Wednesday, November 12th. The company reported $1.01 EPS for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%. The business had revenue of $29.16 million during the quarter.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.